The influence of some immunosuppressive drugs on the metabolic activity of human phagocytes and lymphocytes in vitro

International Journal of Immunopathology and Pharmacology

Volumn 11, Issue 3, 1998, Pages 155-162

  Duskova M ^a   Dusek L ^b   Ciz M ^a   Lojek, A ^a   Slavikova H ^a  

^a INSTITUTE OF BIOPHYSICS   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Blast transformation; Chemiluminescence; Immunosuppression; Reactive oxygen species

Indexed keywords

AZATHIOPRINE; CONCANAVALIN A; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; PROTEIN A; REACTIVE OXYGEN METABOLITE; STARCH; TACROLIMUS; ZYMOSAN;

ARTICLE; BLAST TRANSFORMATION; CHEMOLUMINESCENCE; CONTROLLED STUDY; DNA SYNTHESIS; DOSE RESPONSE; HUMAN; HUMAN CELL; LEUKOCYTE METABOLISM; LYMPHOCYTE; PHAGOCYTE; PRIORITY JOURNAL;

EID: 0031774626     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463209801100305     Document Type: Article

References (26)

1. Allison A.C. 1993. Novel immunosuppressive and antiinflammatory drugs. In Immunosuppressive and Antiimflammatory Drugs. A.C. Allison, K.J. Lafferty, and H. Fliri, ed. Annals of the New York Academy of Sciences. Vol. 696.
2. Burke G.W., R. Alejandro, G. Ciancio, J. Nery, D. Roth, R. Shapiro, V. Scantlebury, J.S. Skyler, C. Ricordi, A. Tzakis and J. Miller. 1995. The use of FK 506 in simultaneous pancreas/kidney transplantation: rescue, induction, and maintenance immunosuppression. Transplant. Proc. 27:3123.
3. Čiž M., A. Lojek, M. Hošek and M. Feilhauerová. 1996. Cadmium ions influence the chemiluminiscence activity of murine splenocytes both in vivo and in vitro. Toxicol. Lett. 86:39.
4. Clipstone N.A. and G.R. Crabtree. 1993. Calcineurin is a key signaling enzyme in T lymphocytes by staphylococcal protein A. J. Immunol. Methods. 47:191.
5. Dwyer J.M. and Ch. Johnson. 1981. The use of concanavalin A to study the immunoregulation of human T cells. Clin. Exp. Immunol. 46:237.
6. Fleischer B. 1981. Induction of T cell growth factor synthesis in human peripheral blood Transplant. Proc. 27:3123.
7. Fukumoto T., Y. Ku, Y. Kuroda and Y. Saitoh. 1995. Identification of primary source of oxygen radicals in hepatic reperfusion injury: Use of novel leukocyte removal system and nitro blue tetrazolium perfusion. Transplant. Proc. 27:1901.
8. Hilbrands L.B., A.J. Hoitsma and R.A.P. Koene. 1995. The effect of immunosuppressive drugs on quality of life after renal transplantation. Transplantation 59:1263.
9. Hodgkin P.D. and M.R. Kehry. 1992. The mechanism of T and B cell collaboration. Immun. Cell Biol. 70: 153.
10. Kino T., H. Hataraka and S. Miyata. 1987. FK 506 a novel immunosuppression isolated from a streptomyces: immunosuppressive effect of FK 506 in vitro. J. Antibiotics 40:1256.
11. Lake K.D. and D.M. Canafax. 1995. Important interactions of drugs with immunosuppressive agents used in transplant recipients. J. Antimicrob. Chemother. 36:11.
12. Lemstrom K.B., A.K.R. Sokolowski, P.J. Hayry and P.K. Koskinen. 1996. Triple drug immunosuppression significantly reduces aortic allograft arteriosclerosis in the rat. Arterioscler. Throm. Vasc. Biol. 16: 553.
13. Lojek A., J. Černý, J. Pillich, M. Čiž, D. Kubíčková, V. Pavlíček, P. Němec and R. Wagner. 1992. Human neutrophil mobilization during open heart surgery. Physiol. Res. 41:431.
14. Lojek A., J. Černý, M. Čiž, J. Vondrácek, H. Slavíková, M. Dušková, P. Němec, R. Wagner and J. Ničovsky. 1996. Phagocyte mobilization during and after the human organ transplantations. Shock 5 (Suppl.):8.
15. Lundgvist H., L.J. Kricka, R. Stott, G.H.G. Thorpe and C. Dahlgren. 1995. Influence of different luminols on the characteristics of chemiluminiscence reaction in human neutrophils. J. Biolumin. Chemilumin. 10:353.
16. Madsen K.L., N.L. Yanchar, D.L. Sigalet, T. Reigel and R.N. Fedorak. 1995. FK 506 increases permeability in rat intestine by inhibiting mitochondrial function. Gastroenterol. 109:107.
17. Morris R.E. 1995. Mechanism of action of new immunosuppressive drugs. Ther. Drug Monit. 17:564.
18. Muraguchi A., J.L. Butler, J.H. Kehrl, R.J. Falkoff and A.S. Fauci. 1983. Selective suppression of an early step in human B cell activation by Cyclosporin A. J.Exp. Med. 158:690.
19. Pham S.M., R.L. Kormos, B.C. Hattler, A. Kawai, A.C. Tsamandas, A. Demetris, S. Murali, F.J. Fricker, H.C. Chang, A.B. Jain, T.E. Starzl, R.L. Hardesty and B.P. Griffith. 1996. Cardiac and pulmonary replacement. A prospective trial of Tacrolimus (FK 506) in clinical heart transplantation: intermediate-term results. J. Thorac. Cardiovasc. Surg. 111:764.
20. Roilides E., T. Robinson, T. Sein, P.A. Pizzo and T.J. Walsh. 1994. In vitro and ex vivo effects of cyclosporine A on phagocytic host defenses against Aspergillus fumigatus. Antimicrob. Agents and Chemother. 38:2883.
21. Sehgal S.N. 1995. Rapamune (Sirolimus, Rapamycin): an overview and mechanism of action. Ther. Drug Monit. 17:660.
22. Shimizu S., W. Kamike, N. Hatanaka, M. Miyata, T. Inoue, Y. Yoshida, K. Tagawa and H. Matsuda. 1994. Beneficial effects of Cyclosporine on reoxygenation injury in hypoxic rat liver. Transplantation 57:1562.
23. Simpson, P.J. and B.R. Lucchesi. 1987. Free radicals and myocardial ischemia and reperfusion injury. J. Lab. Clin. Med. 110:13.
24. Stites D.P. and A.I. Terr. 1991. In Basic and Clinical Immunology. A Publishing Division of Prentice Hall, New Jersey, p. 741.
25. Yoshimura N., S. Matsui, T. Hamashima and T. Oka. 1989. Effect of new immunosuppressive agent, FK 506, on human lymphocyte responses in vitro. Transplantation 47:356.
26. Zar J.H. 1984. In Biostatistical analysis. Prentice Hall. New Jersey, p. 718.